Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-039609
Filing Date
2025-04-28
Accepted
2025-04-25 20:54:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm252386d4_defa14a.htm DEFA14A 14309
2 GRAPHIC tm252386d4_defa14aimg001.jpg GRAPHIC 180871
3 GRAPHIC tm252386d4_defa14aimg002.jpg GRAPHIC 174794
  Complete submission text file 0001104659-25-039609.txt   505655
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 25875745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)